Warren V. Kalina

Pfizer (United States) — United States

Medicine · Health Sciences

26h-index25.8kcitations57works5.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory viral infections research(18), SARS-CoV-2 and COVID-19 Research(17), Viral gastroenteritis research and epidemiology(10), Animal Virus Infections Studies(7), Viral Infections and Outbreaks Research(6)

Publications57 total

Respiratory Syncytial Virus Hospitalizations in Adults ≥50 Years of Age and Those with Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Exacerbations, 2018-2020
Clinical Infectious Diseases·2026
Protective properties of a candidate C-terminal domain OspA vaccine for prevention of Lyme disease
Vaccine·2026Open Access
Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2–<18 Year Olds
Vaccines·2026Open Access
2025 White Paper on Recent Issues in Bioanalysis: Redosing Patients with AAV Gene Therapy; CRS Immunogenicity Risk; Shedding Assays; NHP Studies Immunogenicity; CMC vs Bioanalytical Assays; Artificial Intelligence-Powered Genomic Pipelines for NGS ( <u>PART 3A</u> – Recommendations on Gene, Cell, and Vaccine Therapies Immunogenicity &amp; Technologies; Biotherapeutics &amp; Biosimilars Immunogenicity Assessment &amp; Clinical Relevance <u>PART 3B</u> – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell &amp; Vaccine Therapies)
Bioanalysis·2025Open Access
Molecular characterization of Clostridioides difficile isolated from older adults during prospective population-based active surveillance at nine hospitals in Tokyo, Japan, 2018–2020
Anaerobe·2025· 1 citedOpen Access
Viral Etiologies of Acute Respiratory Illness in Older Adults and of Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Exacerbations Requiring Hospitalization During 2 Prepandemic Respiratory Seasons
Open Forum Infectious Diseases·2025Open Access
Detection by Nasopharyngeal Swabs Alone Underestimates Respiratory Syncytial Virus–Related Hospitalization Incidence in Adults: The Multispecimen Study's Final Analysis
The Journal of Infectious Diseases·2025· 9 citedOpen Access
2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation <u>(PART 3A</u> – Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment &amp; Clinical Relevance <u>PART 3B</u> – Regulatory Agencies’ Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell &amp; Vaccine Therapies)
Bioanalysis·2025· 6 citedOpen Access
Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study’s Final Analysis
2025· 5 citedOpen Access
CLOVER (CLOstridium difficile Vaccine Efficacy tRial) Study: A Phase 3, Randomized Trial Investigating the Efficacy and Safety of a Detoxified Toxin A/B Vaccine in Adults 50 Years and Older at Increased Risk of <i>Clostridioides difficile</i> Infection
Clinical Infectious Diseases·2024· 20 citedOpen Access
Relative Contribution of Diagnostic Testing to the Diagnosis of Respiratory Syncytial Virus in Hospitalized Adults in the United States
The Journal of Infectious Diseases·2024· 9 citedOpen Access
Respiratory Syncytial Virus (RSV) Detection Among Adults With Underlying Cardiopulmonary Disease Hospitalized With Acute Respiratory Illness
2024
Development and validation of a 6-plex Luminex-based assay for measuring human serum antibodies to group B streptococcus capsular polysaccharides
Human Vaccines & Immunotherapeutics·2024· 11 citedOpen Access
2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard <u>(Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity &amp; Technologies; Biotherapeutics Immunogenicity &amp; Risk Assessment; ADA/NAb Assay/Reporting Harmonization)
Bioanalysis·2024· 16 citedOpen Access
861. Development and Clinical Validation of a Custom Modified Two-Tier Testing Algorithm for Serodiagnosis of Lyme Disease
Open Forum Infectious Diseases·2023Open Access
Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis
The Journal of Infectious Diseases·2023· 38 citedOpen Access
Diagnosis of Respiratory Syncytial Virus in Adults Substantially Increases When Adding Sputum, Saliva, and Serology Testing to Nasopharyngeal Swab RT–PCR
Infectious Diseases and Therapy·2023· 92 citedOpen Access
Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis
The Journal of Infectious Diseases·2023· 165 citedOpen Access
Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old
Future Virology·2023· 2 citedOpen Access
Plain Language Summary of Pfizer-BioNTech BNT162b2 COVID-19 Vaccine Safety in Participants at Least 16 Years Old and Protection Against COVID-19 in Participants at Least 12 Years Old
Future Virology·2022Open Access
page 1 of 3Next →

Frequent Co-authors

Kena A. Swanson(16), Özlem Türeci(16), Philip R. Dormitzer(16), Uğur Şahin(16), David Cooper(13), Stephen Lockhart(12), Kathrin U. Jansen(12), Pei‐Yong Shi(12), Nicholas Kitchin(11), Ruth Bailey(11), Kenneth Koury(11), William C. Gruber(11), Camila R. Fontes-Garfias(11), Judith Absalon(10), Alejandra Gurtman(10), Robert W. Frenck(10), Edward E. Walsh(10), Ann R. Falsey(10), Kristin R. Tompkins(9), Kathrin U. Jansen(8)